Moody’s revises Shands Jacksonville Medical Center’s outlook to stable

Moody’s Investors Service affirmed its “Baa3” rating on Shands Jacksonville (Fla.) Medical Center’s outstanding revenue bonds, affecting $197 million of debt.

Advertisement

Concurrently, Moody’s affirmed its “Baa3” issuer default rating on SJMC.

The affirmation is a result of several factors, including SJMC’s role as the academic medical center for University of Florida College of Medicine, strong financial support from the city of Jacksonville and the university and proactive management of covenants. Moody’s also acknowledged the medical center’s variable cash position and challenging payer mix.

The outlook was revised to stable from negative following the completion of the hospitals new inpatient facility, which has generated positive cash flow.

More articles on healthcare finance:
Donations to USC medical school fall 55% after dean, faculty scandals
U of Texas Health renames cancer center after donors of $25M gift
10 recent hospital, health system outlook and credit rating actions

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Financial Management

  • More providers are requiring payment before a medical procedure, the Wall Street Journal reported Sept. 6. The share of U.S.…

  • ACA insurers requested a median rate increase of 15% for 2027, according to a Peterson-KFF Health System Tracker analysis. However,…

Advertisement

Comments are closed.